- Home
- PLMR vs OGN Comparison
PLMR vs OGN Comparison
Compare PLMR & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLMR
- OGN
- Stock Information
- Founded
- PLMR 2013
- OGN 1923
- Country
- PLMR United States
- OGN United States
- Employees
- PLMR N/A
- OGN N/A
- Industry
- PLMR Property-Casualty Insurers
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- PLMR Finance
- OGN Health Care
- Exchange
- PLMR Nasdaq
- OGN Nasdaq
- Market Cap
- PLMR 3.3B
- OGN 2.7B
- IPO Year
- PLMR 2019
- OGN N/A
- Fundamental
- Price
- PLMR $117.21
- OGN $10.76
- Analyst Decision
- PLMR Buy
- OGN Hold
- Analyst Count
- PLMR 8
- OGN 4
- Target Price
- PLMR $156.43
- OGN $18.00
- AVG Volume (30 Days)
- PLMR 287.6K
- OGN 3.6M
- Earning Date
- PLMR 11-03-2025
- OGN 10-30-2025
- Dividend Yield
- PLMR N/A
- OGN 0.76%
- EPS Growth
- PLMR 49.38
- OGN N/A
- EPS
- PLMR 5.68
- OGN 2.69
- Revenue
- PLMR $682,205,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- PLMR $256.23
- OGN N/A
- Revenue Next Year
- PLMR $18.70
- OGN $1.36
- P/E Ratio
- PLMR $20.24
- OGN $3.90
- Revenue Growth
- PLMR 52.98
- OGN N/A
- 52 Week Low
- PLMR $85.00
- OGN $8.01
- 52 Week High
- PLMR $175.85
- OGN $20.96
- Technical
- Relative Strength Index (RSI)
- PLMR 39.93
- OGN 66.02
- Support Level
- PLMR $114.34
- OGN $10.24
- Resistance Level
- PLMR $124.40
- OGN $10.95
- Average True Range (ATR)
- PLMR 3.23
- OGN 0.41
- MACD
- PLMR -0.25
- OGN 0.08
- Stochastic Oscillator
- PLMR 21.79
- OGN 89.34
About PLMR Palomar Holdings Inc. Common stock
Palomar Holdings Inc that provides property and casualty insurance products to individuals and businesses. provide insurance products serving five categories: Earthquake, Inland Marine and Other Property, Casualty, Fronting, and Crop. Company distribute products through multiple channels, including retail agents, program administrators, wholesale brokers, and partnerships with other insurance companies. The companies Earthquake product generate high premium.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.